Alarko Holding A.S. (IST:ALARK)

Market Cap	40.87B
Revenue (ttm)	6.58B
Net Income (ttm)	1.20B
Shares Out	435.00M
EPS (ttm)	2.81
PE Ratio	33.45
Forward PE	n/a
Dividend	2.25 (2.39%)
Ex-Dividend Date	Apr 17, 2025

Volume	3,342,623
Average Volume	3,798,812
Open	94.25
Previous Close	93.95
Day's Range	93.05 - 94.90
52-Week Range	75.15 - 109.00
Beta	-0.27
RSI	65.57
Earnings Date	Aug 26, 2025

About Revance Therapeutics

Alarko Holding A.S., together with its subsidiaries, engages in contracting, energy, industry and trade, tourism, land development, investment, and agriculture businesses in Turkey. The company undertakes in the construction of refineries, chemical, petrochemical, power, industrial, and water and waste water treatment plants, as well as pipelines, transportation, and housing projects. It also produces, distributes, sells, and trades energy; manufactures heating, ventilating, and air conditioning, as well as sells heating, RLC products, and pump...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1954
• Employees: 5,806
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ALARK

Financial Performance

In 2024, Alarko Holding A.S.'s revenue was 7.60 billion, a decrease of -36.56% compared to the previous year's 11.98 billion. Earnings were 1.76 billion, a decrease of -81.63%.